Literature DB >> 8840786

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

J R Govan1, V Deretic.   

Abstract

Respiratory infections with Pseudomonas aeruginosa and Burkholderia cepacia play a major role in the pathogenesis of cystic fibrosis (CF). This review summarizes the latest advances in understanding host-pathogen interactions in CF with an emphasis on the role and control of conversion to mucoidy in P. aeruginosa, a phenomenon epitomizing the adaptation of this opportunistic pathogen to the chronic chourse of infection in CF, and on the innate resistance to antibiotics of B. cepacia, person-to-person spread, and sometimes rapidly fatal disease caused by this organism. While understanding the mechanism of conversion to mucoidy in P. aeruginosa has progressed to the point where this phenomenon has evolved into a model system for studying bacterial stress response in microbial pathogenesis, the more recent challenge with B. cepacia, which has emerged as a potent bona fide CF pathogen, is discussed in the context of clinical issues, taxonomy, transmission, and potential modes of pathogenicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840786      PMCID: PMC239456          DOI: 10.1128/mr.60.3.539-574.1996

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


  436 in total

1.  Signal transduction in exopolysaccharide alginate synthesis: phosphorylation of the response regulator AlgR1 in Pseudomonas aeruginosa and Escherichia coli.

Authors:  S Roychoudhury; K Sakai; D Schlictman; A M Chakrabarty
Journal:  Gene       Date:  1992-03-01       Impact factor: 3.688

2.  Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients.

Authors:  K D Pfeffer; T P Huecksteadt; J R Hoidal
Journal:  Am J Respir Cell Mol Biol       Date:  1993-11       Impact factor: 6.914

Review 3.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

4.  Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT.

Authors:  D J Wozniak; D E Ohman
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

5.  O and H serotyping of Pseudomonas cepacia.

Authors:  A Heidt; H Monteil; C Richard
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

6.  Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment.

Authors:  J E Mortensen; M C Fisher; J J LiPuma
Journal:  Infect Control Hosp Epidemiol       Date:  1995-01       Impact factor: 3.254

7.  Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  P Kubesch; T Dörk; U Wulbrand; N Kälin; T Neumann; B Wulf; H Geerlings; H Weissbrodt; H von der Hardt; B Tümmler
Journal:  Lancet       Date:  1993-01-23       Impact factor: 79.321

8.  Cloning of Escherichia coli and Pseudomonas aeruginosa phosphomannose isomerase genes and their expression in alginate-negative mutants of Pseudomonas aeruginosa.

Authors:  A Darzins; L L Nixon; R I Vanags; A M Chakrabarty
Journal:  J Bacteriol       Date:  1985-01       Impact factor: 3.490

9.  Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.

Authors:  S Steinbach; L Sun; R Z Jiang; P Flume; P Gilligan; T M Egan; R Goldstein
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245

10.  Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  G B Pier; D Desjardins; T Aguilar; M Barnard; D P Speert
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

View more
  642 in total

Review 1.  SNPing away at innate immunity.

Authors:  S J Chanock; C B Foster
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU).

Authors:  E S Garrett; D Perlegas; D J Wozniak
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

3.  Pseudomonas and all that.

Authors:  C A Hart; C Winstanley
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

4.  Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection.

Authors:  J P Pearson; M Feldman; B H Iglewski; A Prince
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.

Authors:  D Dacheux; I Attree; B Toussaint
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 6.  Microbial biofilms: from ecology to molecular genetics.

Authors:  M E Davey; G A O'toole
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 7.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

8.  Loss of Pseudomonas aeruginosa PhpA aminopeptidase activity results in increased algD transcription.

Authors:  S C Woolwine; A B Sprinkle; D J Wozniak
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

Review 9.  Mechanisms of bacterial pathogenicity.

Authors:  J W Wilson; M J Schurr; C L LeBlanc; R Ramamurthy; K L Buchanan; C A Nickerson
Journal:  Postgrad Med J       Date:  2002-04       Impact factor: 2.401

Review 10.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.